Shire Names Snisarenko to Succeed Dempsey as Head of U.S. Ophthalmics Franchise

By Staff
Wednesday, June 21, 2017 12:15 AM LEXINGTON, Mass.—Shire announced this week that John Snisarenko has been named group vice president and head of ophthalmics U.S. franchise.

Johnson & Johnson Vision Names Jonathan Talamo as Chief Medical Officer

By Staff
Friday, June 9, 2017 12:27 AM NEW BRUNSWICK, N.J.—Johnson & Johnson Vision Care has named Dr. Jonathan Talamo as its new chief medical officer (CMO) and worldwide vice president of medical affairs and clinical affairs for Johnson & Johnson Vision, which comprises both its vision care and surgical businesses.

FDA Approves Nicox’s Zerviate, the First Topical Ocular Formulation of Antihistamine Cetirizine

By Staff
Monday, June 5, 2017 12:24 AM OPHIA ANTIPOLIS, France—Nicox S.A. (Euronext Paris: FR0013018124, COX), an ophthalmic research and discovery company, has announced that the Food and Drug Administration (FDA) has approved its new drug Zerviate (cetirizine ophthalmic solution 0.24%), the first topical ocular formulation of this antihistamine.

TearClear Completes $4.5 Million Series A Financing and Introduces Leadership Team

By Staff
Wednesday, May 31, 2017 12:23 AM ORANGE COUNTY, Calif.—TearClear Corp., an early-stage, eye health technology company, reported Tuesday that it completed a Series A financing round that generated proceeds of $4.5 million.

Dr. Brian Marr Named Director of Ophthalmic Oncology at NewYork-Presbyterian/Columbia Medical Center

By Staff
Wednesday, May 24, 2017 12:15 AM NEW YORK—Dr. Brian Marr will join the department of ophthalmology at NewYork-Presbyterian/Columbia University Medical Center as director of the division of ophthalmic oncology, effective May 15.

Georgia Governor Signs Legislation Authorizing ODs to Administer Some Injections

By Staff
Wednesday, May 17, 2017 12:27 AM ATLANTA—Georgia Gov. Nathan Deal last week signed legislation that will allow optometrists to perform certain types of injections in and around the eye.

Bill Hughson Named CEO of Grand Rapids Ophthalmology

By Staff
Monday, May 15, 2017 12:18 AM GRAND RAPIDS, Mich.—Grand Rapids Ophthalmology (GRO)— a comprehensive eyecare provider offering ophthalmology, optometry and retail optical services in West Michigan—announced today the appointment of Bill Hughson as chief executive officer.

Second Sight Posts Losses in First Quarter 2017

By Staff
Friday, May 5, 2017 12:26 AM SYLMAR, Calif.—Second Sight Medical Products (NASDAQ:EYES), maker of the Argus II retinal prosthesis, posted losses for the three months ended March 31, 2017, despite an increase in implant volume of the device.

LensGen Closes $21 Million Financing Round, Led by Hoya

By Staff
Wednesday, May 3, 2017 12:26 AM IRVINE, Calif.—LensGen, a private company developing Juvene, a modular, fluid-optic accommodating intraocular lens, announced that it has closed a $21 million Series A financing.

FDA Says Allergan Can Market Intranasal Tear Neurostimulator

By Staff
Wednesday, May 3, 2017 12:24 AM DUBLIN—The U.S. Food and Drug Administration (FDA) has granted Allergan (NYSE: AGN) marketing authorization for a pocket-sized device designed to temporarily increase tear production in adults.

Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears

By Staff
Wednesday, May 3, 2017 12:15 AM SAN DIEGO, Calif. and SEATTLE, Wash.—Imprimis Pharmaceuticals, Inc., an ophthalmology-focused pharmaceutical company, and SightLife Surgical, a cornea-focused organization providing services to ophthalmic surgeons, announced the signing of an exclusive strategic sales and marketing agreement.

Researchers Develop New AI Algorithm to Detect Diabetic Retinopathy

By Staff
Friday, April 28, 2017 12:24 AM SAN FRANCISCO—In a new study published online in Ophthalmology, the journal of the American Academy of Ophthalmology, researchers from Stanford University’s Byers Eye Institute describe how they used an artificial intelligence method known as deep-learning to create an automated algorithm to detect diabetic retinopathy.

Ophthalmologists Visit Capitol Hill to Discuss Issues Affecting Medical and Surgical Eyecare

By Staff
Friday, April 28, 2017 12:21 AM WASHINGTON—Eye physicians and surgeons representing the American Academy of Ophthalmology (AAO) met with members of Congress this week to discuss many of the primary issues they believe are affecting medical and surgical eyecare.

A House Committee in Florida Legislature Postpones Action on Optometry Bill

By Staff
Monday, April 24, 2017 12:24 AM TALLAHASSEE, Fla.—The Health and Human Services Committee in Florida’s House of Representatives  postponed a vote on a bill that would permit optometrists to perform certain eyecare procedures.

NIH Study Shows Eye Exam Schedule Results in Better Outcomes

By Staff
Monday, April 24, 2017 12:21 AM BETHESDA, Md.—Research results may lead to a reconsideration of how often people with type 1 diabetes should have an eye exam.
Loading...